The electronic cigarette industry and Republican lawmakers are putting pressure on the Supreme Court to ask the Food and Drug Administration (FDA) to adopt the “Lopaliang” ruling in vape regulatory cases. The ruling nullified Chevron’s principle of deference to the actions of executive agencies, and industry and lawmakers wanted to overturn regulatory judgments they said were unfounded under the law and regulations.
According to InsideHealthPolicyreported on October 18. The Washington vape industry and Republican lawmakers are putting pressure on the Supreme Court, saying they are hearing the Food and Drug Administration (FDA) to use the Supreme Court’s “Loper Bright” ruling, The Loper Bright ruling on the regulation of electronic cigarettes is a good opportunity. The ruling struck down the “Chevron” principle of deference to the actions of executive agencies, and industry and lawmakers wanted to overturn regulatory judgments they said were unfounded under the law and regulations.
The brief filed by the industry notes that the FDA and Wages case involving White Lion Investments LLC applies to a retrial after the “Chevron” decision. At the same time, the opinion of several lawmakers also supports this view. They see this as key to examining the legality of current vapee regulation.
Experts said that if the Supreme Court adopts the principles of the “Lopaliang” ruling, it may significantly impact the future regulation of multiple industries, providing a new judicial standard for the regulatory measures of administrative units. The vape industry and its supporters hope to find a more favorable regulatory environment through litigation to promote the sector’s development.
